Integer Holdings (ITGR) Stock Forecast & Price Target

Integer Holdings Corp has demonstrated solid revenue growth in its Cardio & Vascular segment, achieving a 15% increase in 3Q25, while maintaining stable gross margins projected at 27.3% for 2025E and 27.0% for 2026E. The company forecasts revenues of $1.87 billion for 2026E, reflecting a modest increase over the previous year, alongside consistent earnings per share of $6.30, indicating stable financial performance amidst market growth. Additionally, an anticipated rise in operating cash flow to $230-$240 million contributes to favorable leverage ratios, positioning Integer advantageously within a robust and innovative cardiovascular device market.

Integer Holdings Corp's financial outlook appears negative as the company has revised its fourth-quarter revenue estimates downward to $460.0 million, reflecting only a 2% increase year-over-year, and has adjusted its adjusted EPS estimates lower to $1.66 from a previous projection of $1.75. Additionally, management has provided a disappointing full-year 2026 organic revenue guidance of flat to +3%, down from a prior expectation of flat to +4%, indicating a stagnation in growth driven by reduced demand in key product lines. Furthermore, the company's forecast for 1Q growth is projected to be flat to down low single digits, suggesting potential downside risk if the contributions from mergers and acquisitions do not meet expectations or if core sales do not materialize as anticipated.